Document is current
Any future updates will be listed below
-
Authors
Gitto, Sarah B. https://orcid.org/0000-0001-6496-4528
Pantel, Austin R.
Maxwell, Kara N. https://orcid.org/0000-0001-8192-4202
Pryma, Daniel A.
Farwell, Michael D. https://orcid.org/0000-0003-0650-4747
Liu, Fang https://orcid.org/0000-0003-2922-4414
Cao, Quy
O’Brien, Sophia R.
Clark, Amy S.
Shah, Payal D.
McDonald, Elizabeth S. https://orcid.org/0000-0002-7209-4216
-
Funding
Funding for this research was provided by:
METAvivor
- License Information
-
More Information
Article History
Received: 14 August 2024
Accepted: 27 February 2025
First Online: 25 March 2025
Competing interests
: D.A.P. serves on the advisory board and licensed a patent to Trevarx Biomedical, a company with a license to [18F]FTT, the radiopharmaceutical investigated in this study. All other authors have declared that no conflicts of interest exist.
